Literature DB >> 10634451

Familial aggregation of Alzheimer disease among whites, African Americans, and Caribbean Hispanics in northern Manhattan.

G Devi1, R Ottman, M X Tang, K Marder, Y Stern, R Mayeux.   

Abstract

BACKGROUND: Alzheimer disease (AD) aggregates in families.
OBJECTIVE: To compare the familial aggregation and lifetime risk of AD to the age of 90 years in the first-degree relatives of patients with AD and unrelated controls among Caribbean Hispanics, African Americans, and whites in Washington Heights, Manhattan, New York, NY.
METHODS: Family history of AD and demographic information were obtained from informants of 435 patients with probable or possible AD concerning 1577 siblings and parents and from 1094 controls without dementia concerning 3952 siblings and parents.
RESULTS: Lifetime risk of AD to the age of 90 years was 25.9% in relatives of patients and 19.1% in relatives of controls. Rate ratio (RR) for AD in relatives of patients compared with relatives of controls was 1.5 overall (95% confidence interval [CI], 1.2-1.9), and was greater for siblings (RR, 1.8; 95% CI, 1.2-2.5) than for parents (RR, 1.2; 95% CI, 0.9-1.8). Within ethnic groups, RR for AD among relatives was significantly elevated in whites (RR, 2.0; 95% CI, 1.2-3.3) and Hispanics (RR, 1.5; 95% CI, 1.1-2.1), but the difference did not reach statistical significance in African Americans (RR, 1.4; 95% CI, 0.7-2.7). Risk of AD was greater among relatives who were women compared with men (RR, 1.5; 95% CI, 1.2-1.9).
CONCLUSIONS: Familial aggregation of AD was increased among families of patients compared with those of controls in all 3 ethnic groups. Risk of AD was highest among siblings and women relatives.

Entities:  

Mesh:

Year:  2000        PMID: 10634451     DOI: 10.1001/archneur.57.1.72

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  11 in total

1.  Familial risk for Alzheimer's disease alters fMRI activation patterns.

Authors:  Susan Spear Bassett; David M Yousem; Catherine Cristinzio; Ivana Kusevic; Michael A Yassa; Brian S Caffo; Scott L Zeger
Journal:  Brain       Date:  2006-05       Impact factor: 13.501

Review 2.  Epigenomics of Alzheimer's disease.

Authors:  David A Bennett; Lei Yu; Jingyun Yang; Gyan P Srivastava; Cristin Aubin; Philip L De Jager
Journal:  Transl Res       Date:  2014-05-16       Impact factor: 7.012

3.  SEMIPARAMETRIC TRANSFORMATION MODELS WITH MULTILEVEL RANDOM EFFECTS FOR CORRELATED DISEASE ONSET IN FAMILIES.

Authors:  Baosheng Liang; Yuanjia Wang; Donglin Zeng
Journal:  Stat Sin       Date:  2019       Impact factor: 1.261

4.  A novel gene derived from a segmental duplication shows perturbed expression in Alzheimer's disease.

Authors:  Dimitrios Avramopoulos; Ruihua Wang; David Valle; M Daniele Fallin; Susan S Bassett
Journal:  Neurogenetics       Date:  2007-02-16       Impact factor: 2.660

Review 5.  Use of functional magnetic resonance imaging in the early identification of Alzheimer's disease.

Authors:  Christina E Wierenga; Mark W Bondi
Journal:  Neuropsychol Rev       Date:  2007-05-03       Impact factor: 7.444

6.  Semantic memory activation in individuals at risk for developing Alzheimer disease.

Authors:  M Seidenberg; L Guidotti; K A Nielson; J L Woodard; S Durgerian; P Antuono; Q Zhang; S M Rao
Journal:  Neurology       Date:  2009-08-25       Impact factor: 9.910

Review 7.  Chasing genes in Alzheimer's and Parkinson's disease.

Authors:  Aida M Bertoli-Avella; Ben A Oostra; Peter Heutink
Journal:  Hum Genet       Date:  2004-03-04       Impact factor: 4.132

8.  Neuroglobin and Alzheimer's dementia: genetic association and gene expression changes.

Authors:  Megan Szymanski; Ruihua Wang; M Danielle Fallin; Susan S Bassett; Dimitrios Avramopoulos
Journal:  Neurobiol Aging       Date:  2008-11-17       Impact factor: 4.673

9.  Bundle-specific associations between white matter microstructure and Aβ and tau pathology in preclinical Alzheimer's disease.

Authors:  Alexa Pichet Binette; Guillaume Theaud; François Rheault; Maggie Roy; D Louis Collins; Johannes Levin; Hiroshi Mori; Jae Hong Lee; Martin Rhys Farlow; Peter Schofield; Jasmeer P Chhatwal; Colin L Masters; Tammie Benzinger; John Morris; Randall Bateman; John Cs Breitner; Judes Poirier; Julie Gonneaud; Maxime Descoteaux; Sylvia Villeneuve
Journal:  Elife       Date:  2021-05-13       Impact factor: 8.140

10.  Evidence of shared risk for Alzheimer's disease and Parkinson's disease using family history.

Authors:  Ami R Rosen; N Kyle Steenland; John Hanfelt; Stewart A Factor; James J Lah; Allan I Levey
Journal:  Neurogenetics       Date:  2007-09-06       Impact factor: 2.660

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.